SARS-CoViD-Endotheliitis Study via Retinal Vascular Analysis (COVID-19)

SARS-CoViD-Endotheliitis Study via Retinal Vascular Analysis (COVID-19) - VoViThel

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023334

Enrollment

Registered

2020-10-30

Start date

2020-09-14

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: Patients with CoViD-19 are teste via dynamic and static retinal vessel analysis, if hospitalisation is ongoing we measure them weekly. After discharge there is a final measurement 6 weeks aft

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: CoViD-19

Exclusion criteria

Exclusion criteria: photosensitive epilepsie, elevated intraocular pressure, pregnancy

Design outcomes

Primary

Measure	Time frame
Association of FID art, FID ven, FIC art (Parameters of dynamic vessel Analysis) with the parameter "Intensive Care Therapy"	—

Secondary

Measure	Time frame
FID art, FID ven and FIC art differ significantly during CoViD-19 in comparison to normal values CRAE, CRVE, CRAE/CRVE Ratio (Parameters of static vessel Analysis) differ significantly during CoViD-19 in comparison to normal values FID art, FID ven and FIC art Change during the course of CoViD-19 Association of the aforementioned Parameters with Ventilation The predictive value of FID art, FID ven, FIC art are better than CrP	—

Measure

Time frame

FID art, FID ven and FIC art differ significantly during CoViD-19 in comparison to normal values CRAE, CRVE, CRAE/CRVE Ratio (Parameters of static vessel Analysis) differ significantly during CoViD-19 in comparison to normal values FID art, FID ven and FIC art Change during the course of CoViD-19 Association of the aforementioned Parameters with Ventilation The predictive value of FID art, FID ven, FIC art are better than CrP

—

Countries

Germany

Contacts

Public ContactRichard Biedermann

Uniklinikum Jena

richard.biedermann@med.uni-jena.de036419329631

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026